"Developing novel treatments for Dormant Cancers - targeting resistance, metastasis, and relapse."

April 28, 2020              AACR Annual Meeting

 

Abstract Number: 5161

Validation of drug candidates targeting dormant cancers in live cells as a key for successful translation into the clinics

Date and Time: Tuesday April 28, 2020; 8:00 a.m. - 12:00 p.m. EDT

April 2, 2019                AACR Annual Meeting

 

Abstract Number: 3038

Implications of DYRK1B kinase in ovarian cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for ovarian cancers

Session: Drug Resistance 4

Date and Time: Tuesday April 2, 2019; 8:00 a.m. - 12:00 p.m. EDT

Location:  Exhibit Hall B; Poster Section 12; Poster Board Number 30

February, 2019             Journal of Molecular Modeling

 

How to design potent and selective DYRK1B inhibitors? Molecular modeling study.

January 11, 2016          8th Annual BIOTECH Showcase

Oral presentation

Date and Time:  January 13th 2016 8AM

Location: The Parc 55 San Francisco Track A